Cox regression analysis for recurrence and distant metastasis incorporating reduced confidence groups. The multivariate model is based on 244 cases with complete data for all variables assessed. (DOCX 13 kb
Background: The clinical and pathological features of primary melanoma are not sufficiently sensitiv...
Associations of KIRREL protein expression with clinicopathological factors in the entire cohort. (DO...
Kaplan-Meier estimates for overall survival according to disease stage. Patients were staged accordi...
Cox regression analysis for distant metastasis-free (DMFS) and overall survival (OS) in the 322-subj...
Survival outcomes for stage IIIA and combined stage IIIB & IIIC patients with molecular classificati...
Supplemental Methods for the 523-patient cohort. These methods describe the generation of four subcl...
Table S1 Clinical characteristics of the melanoma cohort. Table S2 Survival analyses for studied bio...
Kaplan-Meier curve illustrating overall survival according to high and low mRNA expression (median c...
Additional file 1: Supplementary Figure 1. The workflow of this study and consensus matrixes of scre...
Cox regression analysis of hazard ratios for A) recurrence and B) death from melanoma in thin melano...
Additional file 2: Supplementary Figure 2. The correlation of IRGscore with tumor mutation burden
Table S1 Lot-to-lot stability of reagents used to run the DecisionDx-Melanoma test. (DOCX 14 kb
pT stage by UICC Stage of malignant melanoma patients diagnosed between 2002 and 2011 (N = 61 895) (...
Table S1. Response Metrics (per RECIST) in Melanoma Patients (Ipilimumab-Naive Melanoma (KEYNOTE -00...
Expression levels of microRNAs in melanoma cells and healthy adjacent skin to a real-time PCR analys...
Background: The clinical and pathological features of primary melanoma are not sufficiently sensitiv...
Associations of KIRREL protein expression with clinicopathological factors in the entire cohort. (DO...
Kaplan-Meier estimates for overall survival according to disease stage. Patients were staged accordi...
Cox regression analysis for distant metastasis-free (DMFS) and overall survival (OS) in the 322-subj...
Survival outcomes for stage IIIA and combined stage IIIB & IIIC patients with molecular classificati...
Supplemental Methods for the 523-patient cohort. These methods describe the generation of four subcl...
Table S1 Clinical characteristics of the melanoma cohort. Table S2 Survival analyses for studied bio...
Kaplan-Meier curve illustrating overall survival according to high and low mRNA expression (median c...
Additional file 1: Supplementary Figure 1. The workflow of this study and consensus matrixes of scre...
Cox regression analysis of hazard ratios for A) recurrence and B) death from melanoma in thin melano...
Additional file 2: Supplementary Figure 2. The correlation of IRGscore with tumor mutation burden
Table S1 Lot-to-lot stability of reagents used to run the DecisionDx-Melanoma test. (DOCX 14 kb
pT stage by UICC Stage of malignant melanoma patients diagnosed between 2002 and 2011 (N = 61 895) (...
Table S1. Response Metrics (per RECIST) in Melanoma Patients (Ipilimumab-Naive Melanoma (KEYNOTE -00...
Expression levels of microRNAs in melanoma cells and healthy adjacent skin to a real-time PCR analys...
Background: The clinical and pathological features of primary melanoma are not sufficiently sensitiv...
Associations of KIRREL protein expression with clinicopathological factors in the entire cohort. (DO...
Kaplan-Meier estimates for overall survival according to disease stage. Patients were staged accordi...